Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome

NCT06953466 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Netherton Syndrome

Interventions

DRUG: QRX003, 4% Lotion

Sponsor

Quoin Pharmaceuticals